All questionsDosing and administration: Biktarvy (bictegravir, emtricitabine, and tenofovir alafenamide) in HIV-1 infection4 questions · 3 sourcesDosingWhat is the Biktarvy dosage for adults and children?“Dosage: Adult and pediatric patients weighing ≥25 kg: 1 tablet containing 50 mg bictegravir (BIC), 200 mg emtricitabine (FTC), and 25 mg tenofovir alafenamide (TAF) taken once daily with or without food. Pediatric patients weighing ≥14 kg to <25 kg: 1 tablet containing 30 mg BIC, 120 mg FTC, and 15 mg TAF taken once daily with or without food. For these pediatric patients, who are unable to swallow a whole tablet, the tablet can be split and each part taken separately as long as all parts are ingested within approximately 10 minutes.” (opens the source at this quote in a new tab)CopyFlagTaking treatmentDoes Biktarvy need to be taken with food?“Take BIKTARVY 1 time each day with or without food.” (opens the source at this quote in a new tab)CopyFlag“Pharmacokinetic Properties of the Components of BIKTARVY Bictegravir (BIC) Emtricitabine (FTC) Tenofovir Alafenamide (TAF)” (opens the source at this quote in a new tab)CopyFlag“Effect of high-fat meal (relative to fasting)b AUC ratio 1.24 (1.16, 1.33) 0.96 (0.93, 0.99) 1.63 (1.43, 1.85) Cmax ratio 1.13 (1.06, 1.20) 0.86 (0.78, 0.93) 0.92 (0.73, 1.14)” (opens the source at this quote in a new tab)CopyFlag“b. Values refer to geometric mean ratio [high-fat meal/ fasting] in PK parameters and (90% confidence interval). High fat meal is approximately 800 kcal, 50% fat.” (opens the source at this quote in a new tab)CopyFlagNote: Each row of Table 4 lists values in header order: bictegravir (BIC), emtricitabine (FTC), then tenofovir alafenamide (TAF).Before treatmentWhat tests are needed before starting Biktarvy?“Testing with BIKTARVY according to the Prescribing Information2 Prior to or when initiating BIKTARVY, and during treatment, assess serum creatinine, estimated creatinine clearance, urine glucose, and urine protein in all patients as clinically appropriate. In patients with chronic kidney disease, assess serum phosphorus. Prior to or when initiating BIKTARVY, test for HBV infection. Prescribing Information contains no HLA-B*5701 testing requirement.” (opens the source at this quote in a new tab)CopyFlagCan Biktarvy be started before baseline lab results are back?“According to the DHHS guidelines, BIKTARVY can be started immediately in your appropriate patients1 The following tests should be performed at treatment initiation; however, you do not have to wait for the results before starting your patients on BIKTARVY, except for in individuals with a history of long-acting cabotegravir as pre-exposure prophylaxis, where genotype testing done before the start of ART should include screening for integrase strand transfer inhibitor (INSTI)-resistance mutations. Because of the long half-life of CAB-LA, persistent drug exposure at levels suboptimal to prevent infection may select for INSTI-resistant virus.1 Resistance testing HBV testing CD4 testing Viral load testing Once test results are received, the treatment regimen can be modified if needed1” (opens the source at this quote in a new tab)CopyFlag“BIKTARVY is not indicated for patients with known or suspected substitutions associated with resistance to bictegravir or tenofovir.2” (opens the source at this quote in a new tab)CopyFlag